{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:45:55Z","timestamp":1790790355183,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["502-03\/5-139-02\/502-54-008"],"award-info":[{"award-number":["502-03\/5-139-02\/502-54-008"]}]},{"name":"Polish Ministry of Science and Higher Education","award":["IP2011003271"],"award-info":[{"award-number":["IP2011003271"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.ijcard.2016.07.150","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T23:27:58Z","timestamp":1468538878000},"page":"1073-1080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies"],"prefix":"10.1016","volume":"221","author":[{"given":"Agata","family":"Bielecka-Dabrowa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Sakowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Misztal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Pietrucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Rysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 Suppl.","key":"10.1016\/j.ijcard.2016.07.150_bb0005","doi-asserted-by":"crossref","first-page":"S442","DOI":"10.1016\/j.cjca.2014.09.032","article-title":"The epidemic of heart failure: a lucid approach to stemming the rising tide","volume":"30","author":"O'Meara","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0010","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/eurjhf\/hft106","article-title":"Biomarkers of heart failure with normal ejection fraction: a systematic review","volume":"15","author":"Cheng","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/eurjhf\/hfn036","article-title":"Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover","volume":"11","author":"Martos","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cca.2014.09.014","article-title":"Personalized risk assessment of heart failure patients: more perspectives from transforming growth factor super-family members","volume":"443","author":"Goletti","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"443","key":"10.1016\/j.ijcard.2016.07.150_bb0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2014.10.023","article-title":"Multiple biomarker strategies for risk stratification in heart failure","volume":"30","author":"Bayes-Genis","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.ijcard.2016.07.150_bb0030","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2217\/pgs.09.101","article-title":"Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension","volume":"10","author":"Wilke","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ijcard.2016.07.150_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcm.2005.07.005","article-title":"Cardiomyocyte-specific overexpression of nitric oxide synthase 3: impact on left ventricular function and myocardial infarction","volume":"15","author":"Bloch","year":"2005","journal-title":"Trends Cardiovasc. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2016.07.150_bb0040","first-page":"A12171","article-title":"Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension","volume":"130","author":"Bielecka-Dabrowa","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.150_bb0045","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.1038\/srep08916","article-title":"Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension","volume":"5","author":"Bielecka-Dabrowa","year":"2015","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ijcard.2016.07.150_bb0050","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.3390\/ijms160510715","article-title":"The multi-biomarker approach for heart failure in patients with hypertension","volume":"16","author":"Bielecka-Dabrowa","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ijcard.2016.07.150_bb0055","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/HJH.0b013e3283569a9c","article-title":"An update on biomarkers of heart failure in hypertensive patients","volume":"30","author":"Gluba","year":"2012","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.ijcard.2016.07.150_bb0060","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ijcard.2013.01.157","article-title":"Heart failure biomarkers in patients with dilated cardiomyopathy","volume":"68","author":"Bielecka-Dabrowa","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.07.150_bb0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"Lang","year":"2006","journal-title":"Eur. J. Echocardiogr."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0070","series-title":"Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels","first-page":"253","author":"The Criteria Committee of the New York Heart Association","year":"1994"},{"issue":"6","key":"10.1016\/j.ijcard.2016.07.150_bb0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Modification of Diet in Renal Disease Study Group","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2016.07.150_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2016.07.150_bb0085","doi-asserted-by":"crossref","first-page":"e99495","DOI":"10.1371\/journal.pone.0099495","article-title":"Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology","volume":"9","author":"Putko","year":"201412","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.07.150_bb0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCHEARTFAILURE.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","article-title":"Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats","volume":"106","author":"Kuwahara","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.150_bb0100","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1016\/j.jacc.2014.02.572","article-title":"Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through pro-inflammatory effects and endothelial-mesenchymal transition","volume":"63","author":"Murdoch","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000329681","article-title":"Replicative aging induces endothelial to mesenchymal transition in human aortic endothelial cells: potential role of inflammation","volume":"49","author":"Fleenor","year":"2012","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0110","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/09553002.2013.763193","article-title":"The effect of oxidized low-density lipoprotein (ox-LDL) on radiation-induced endothelial-to-mesenchymal transition","volume":"89","author":"Kim","year":"2013","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00395-014-0428-7","article-title":"Cardiac fibroblasts support cardiac inflammation in heart failure","volume":"109","author":"Lindner","year":"2014","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.hlc.2012.12.002","article-title":"Therapeutic potential of tumour necrosis factor-alpha antagonists in patients with chronic heart failure","volume":"22","author":"Javed","year":"2013","journal-title":"Heart Lung Circ."},{"issue":"9","key":"10.1016\/j.ijcard.2016.07.150_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002251","article-title":"Molecular signature of nitroso-redox balance in idiopathic dilated cardiomyopathies","volume":"4","author":"Menazza","year":"2015","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.ijcard.2016.07.150_bb0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12265-013-9462-3","article-title":"New and emerging biomarkers in left ventricular systolic dysfunction \u2014 insight into dilated cardiomyopathy","volume":"6","author":"Gopal","year":"2013","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"12","key":"10.1016\/j.ijcard.2016.07.150_bb0140","first-page":"1755","article-title":"Association of genetic polymorphisms with endothelial dysfunction in chronic heart failure","volume":"18","author":"Kose","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ijcard.2016.07.150_bb0145","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ahj.2004.05.059","article-title":"A polymorphism of the endothelial nitric oxide synthase promoter is associated with an increase in autonomic imbalance in patients with congestive heart failure","volume":"149","author":"Binkley","year":"2005","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2016.07.150_bb0150","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0735-1097(01)01576-5","article-title":"Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathy","volume":"38","author":"Tsutamoto","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2016.07.150_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcard.2010.04.053","article-title":"Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP\/TIMP profiles","volume":"151","author":"Polyakova","year":"201118","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.07.150_bb0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1017\/S1047951113001820","article-title":"Procollagen type III amino-terminal propeptide: a serum biomarker of left ventricular remodelling in paediatric dilated cardiomyopathy","volume":"25","author":"Kaufman","year":"2015","journal-title":"Cardiol. Young"},{"issue":"10","key":"10.1016\/j.ijcard.2016.07.150_bb0165","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/febs.12161","article-title":"Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart","volume":"280","author":"Strand","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jjcc.2011.01.012","article-title":"Serum syndecan-4 is a novel biomarker for patients with chronic heart failure","volume":"57","author":"Takahashi","year":"2011","journal-title":"J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2016.07.150_bb0175","first-page":"866","article-title":"Changes and clinical significance of serum level of syndecan-4 protein in patients with chronic congestive heart failure","volume":"29","author":"Ma","year":"2013","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.ijcard.2016.07.150_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/eurjhf\/hfs003","article-title":"Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal probrain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study","volume":"14","author":"Carlsen","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.ijcard.2016.07.150_bb0185","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/CIRCRESAHA.110.235689","article-title":"Syndecan-4 prevents cardiac rupture and dysfunction after myocardial infarction","volume":"108","author":"Matsui","year":"2011","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.ijcard.2016.07.150_bb0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00392-010-0248-1","article-title":"Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure","volume":"100","author":"Behnes","year":"2011","journal-title":"Clin. Res. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2016.07.150_bb0195","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1253\/circj.CJ-14-0511","article-title":"Enhanced bioactive myocardial transforming growth factor-\u03b2 in advanced human heart failure","volume":"78","author":"Khan","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.07.150_bb0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCRESAHA.107.157677","article-title":"Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts","volume":"102","author":"Li","year":"2008","journal-title":"Circ. Res."},{"issue":"22","key":"10.1016\/j.ijcard.2016.07.150_bb0205","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s00018-006-6085-8","article-title":"Role of transforming growth factor-beta in the progression of heart failure","volume":"63","author":"Lim","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.ijcard.2016.07.150_bb0210","first-page":"1","article-title":"Inflammation and oxidative stress caused by nitric oxide synthase uncoupling might lead to left ventricular diastolic and systolic dysfunction in patients with hypertension","volume":"12","author":"Szel\u00e9nyi","year":"2015","journal-title":"J. Geriatr. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2016.07.150_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1871529X11313020010","article-title":"Oxidative stress and transforming growth factor-\u03b21-induced cardiac fibrosis","volume":"13","author":"Purnomo","year":"2013","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2016.07.150_bb0220","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1186\/2050-6511-16-S1-A1","article-title":"LCZ696 (sacubitril\/valsartan), an angiotensin receptor neprilysin inhibitor (ARNI): clinical development in heart failure","volume":"16","author":"Lefkowitz","year":"2015","journal-title":"BMC Pharmacol. Toxicol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316315066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316315066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T10:56:44Z","timestamp":1536577004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316315066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":44,"alternative-id":["S0167527316315066"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.150","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}